Moderna’s Vaccine Rally Takes $427 Million Bite Out of Shorts

(Bloomberg) -- Betting against Moderna Inc. may be a risky proposition right now after a first look at its Covid-19 vaccine in humans drove the shares to fresh highs. The stock is ripe for a short ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.